Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02345226
Brief Title: Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

First Submitted : January 19, 2015
First Submitted that Met QC Criteria : January 19, 2015
First Posted : January 26, 2015 (Estimate)

Results First Submitted : September 21, 2017
Results First Submitted that Met QC Criteria : September 21, 2017
Results First Posted : October 19, 2017

Certification/Extension First Submitted : February 14, 2017
Certification/Extension First Submitted that Met QC Criteria : February 14, 2017
Certification/Extension First Posted : February 16, 2017

Last Update Submitted that Met QC Criteria : February 25, 2019
Last Update Posted : March 6, 2019